CellaVision AB (publ) (STO:CEVI)
Sweden · Delayed Price · Currency is SEK 199.80
+8.80 (4.61%)
Nov 4, 2026, 5:29 PM CET
CellaVision AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 763.02 | 758.97 | 723.22 | 677.29 | 639.34 | 565.55 | |
Revenue Growth | 1.95% | 4.94% | 6.78% | 5.94% | 13.05% | 19.96% |
Cost of Revenue | 244.09 | 239.09 | 236.14 | 214.25 | 201.02 | 173.25 |
Gross Profit | 518.93 | 519.88 | 487.07 | 463.04 | 438.32 | 392.3 |
Selling, General & Admin | 239.46 | 220.23 | 221.95 | 212.66 | 191.5 | 165.32 |
Research & Development | 104.24 | 97.58 | 87.45 | 83.33 | 88.55 | 64.25 |
Operating Expenses | 343.7 | 317.8 | 309.4 | 295.99 | 280.05 | 229.57 |
Operating Income | 175.23 | 202.07 | 177.68 | 167.05 | 158.27 | 162.73 |
Interest Expense | - | -0.89 | -1.89 | -3.26 | -2.34 | -1.87 |
Interest & Investment Income | 7.71 | 1.07 | 2.13 | 0.9 | 0.2 | 0.06 |
Currency Exchange Gain (Loss) | -7.99 | -7.99 | -1.06 | -0.47 | -7.7 | -2.63 |
Other Non Operating Income (Expenses) | - | - | - | -0 | - | 0 |
EBT Excluding Unusual Items | 174.96 | 194.26 | 176.86 | 164.22 | 148.43 | 158.3 |
Pretax Income | 174.96 | 194.26 | 176.86 | 164.22 | 148.43 | 158.3 |
Income Tax Expense | 37.04 | 41.19 | 36.14 | 33.91 | 30.09 | 32.96 |
Net Income | 137.92 | 153.08 | 140.72 | 130.31 | 118.34 | 125.34 |
Net Income to Common | 137.92 | 153.08 | 140.72 | 130.31 | 118.34 | 125.34 |
Net Income Growth | -8.91% | 8.78% | 7.99% | 10.12% | -5.59% | 40.08% |
Shares Outstanding (Basic) | 24 | 24 | 24 | 24 | 24 | 24 |
Shares Outstanding (Diluted) | 24 | 24 | 24 | 24 | 24 | 24 |
Shares Change | - | - | - | - | - | - |
EPS (Basic) | 5.78 | 6.42 | 5.90 | 5.46 | 4.96 | 5.25 |
EPS (Diluted) | 5.78 | 6.42 | 5.90 | 5.46 | 4.96 | 5.25 |
EPS Growth | -8.91% | 8.78% | 7.99% | 10.12% | -5.59% | 40.13% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 198.33 | 181.72 | 186.44 | 164.67 | 113.8 | 146 |
Free Cash Flow Per Share | 8.31 | 7.62 | 7.82 | 6.90 | 4.77 | 6.12 |
Dividend Per Share | 2.750 | 2.750 | 2.500 | 2.250 | 2.250 | 2.000 |
Dividend Growth | 10.00% | 10.00% | 11.11% | 0% | 12.50% | 166.67% |
Gross Margin | 68.01% | 68.50% | 67.35% | 68.37% | 68.56% | 69.37% |
Operating Margin | 22.97% | 26.63% | 24.57% | 24.66% | 24.75% | 28.77% |
Profit Margin | 18.08% | 20.17% | 19.46% | 19.24% | 18.51% | 22.16% |
Free Cash Flow Margin | 25.99% | 23.94% | 25.78% | 24.31% | 17.80% | 25.82% |
EBITDA | 198.5 | 221.67 | 199.29 | 187.46 | 176.47 | 178.82 |
EBITDA Margin | 26.02% | 29.21% | 27.56% | 27.68% | 27.60% | 31.62% |
D&A For EBITDA | 23.27 | 19.59 | 21.62 | 20.41 | 18.21 | 16.09 |
EBIT | 175.23 | 202.07 | 177.68 | 167.05 | 158.27 | 162.73 |
EBIT Margin | 22.97% | 26.63% | 24.57% | 24.66% | 24.75% | 28.77% |
Effective Tax Rate | 21.17% | 21.20% | 20.43% | 20.65% | 20.28% | 20.82% |